A burgeoning literature also establishes the biological plausibility of TAAR1 agonists addressing both mania and depression (60, 63), in addition to anxiety (64), psychosis (65), and features of ADHD (60, 66). The gene discussed is TAAR1; the disease is attention deficit-hyperactivity disorder.